Science
Mechanism of Action
This oligopeptide is theorized to function as a cellular signaling molecule within the skin. It is posited to stimulate the production of critical dermal components such as collagen and elastin, simultaneously promoting the generation of new dermal cells. This encourages enhanced cellular renewal and repair, aiming to improve overall skin tone and radiance.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Peptides containing sulfur amino acids, such as methionine, are susceptible to oxidation and oligomerization, which may be mitigated by reducing agents or an inert atmosphere during formulation. Optimal incorporation into products typically occurs at the end of the formulation process, at temperatures around 35-40 °C.
Safety
Safety Profile
Oligopeptide-35 has not been specifically reviewed by regulatory bodies such as CIR, SCCS, or FDA. General GHS hazard classification and specific toxicity data (oral, dermal, inhalation) are not readily available. While the CIR previously noted a general concern about angiogenesis stimulation for *random* peptide sequences, this concern does not constitute a direct safety assessment or restriction for Oligopeptide-35. Peptides in general are typically considered well-tolerated.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While offering promising manufacturer-declared benefits for anti-aging and skin rejuvenation, Oligopeptide-35 requires further independent clinical validation and comprehensive regulatory safety assessments to establish a more robust profile.
Related
Similar Ingredients
Finding similar ingredients…